BLS Pharmaceuticals Limited (ASX: BLS)
Health Care · Life Sciences Tools & Services · AU
AU$1.02
-0.97% today · +209.1% 1Y
BLS Pharmaceuticals Limited (ASX: BLS) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $163.93M and employs 16 people.
Over the last twelve months the share price has gained 209.1%, trading between 0.33 and 1.30.
Tweenvest scores BLS Pharmaceuticals Limited across four factors: quality 69/100, value 55/100, growth 100/100. Its strongest factor is growth.
BLS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $163.93M
- Revenue (TTM)
- $51.13M
- P/E
- 15.22
- EPS
- 0.07
- Dividend yield
- —
- Beta (5Y)
- 0.55
- 52-week high
- AU$1.30
- 52-week low
- AU$0.33
- Avg volume (3M)
- —
- Shares outstanding
- 230.30M
- Employees
- 16
- Next earnings
- —
About BLS Pharmaceuticals Limited
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
- ISIN
- AU0000477796
- Listed since
- Dec 12, 2000
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Tarsons Products LimitedNSEI: TARSONS | $176.45M | Rs320.95 | -2.57% |
| Fine Foods & Pharmaceuticals N.T.M. S.p.A.BIT: FF | $168.81M | €6.66 | -0.60% |
| BICO Group AB (publ)OM: BICO | $167.28M | Skr24.35 | +2.74% |
| Vitrafy Life Sciences LimitedASX: VFY | $165.37M | AU$3.11 | -12.64% |
| Quanterix CorporationNasdaqGM: QTRX | $155.12M | $3.16 | -3.66% |
| Codexis, Inc.NasdaqGS: CDXS | $154.40M | $1.38 | -2.48% |
| FutureChem Co.,LtdKOSDAQ: A220100 | $140.90M | ₩7,040.00 | -2.09% |
| Genovis AB (publ.)OM: GENO | $136.95M | Skr20.40 | +0.49% |
Figures last refreshed Oct 11, 2026.